Using fictional patient profiles and a questionnaire on recommendation procedures, researchers were able to demonstrate a need for standardized tumor board interpretation and recommendation processes worldwide.
An examination of the parameters of a cell’s nucleus can help identify the molecular markers of breast cancer tumors.
Using mathematical analysis, researchers identified factors to help determine if containment or the elimination of an infection or tumor, is most effective.
A new targeted therapy approach may attack cancer on two fronts, boosting anti-tumor immune responses while also directly killing tumor cells .
IH-induced exosomes from mice significantly promote TC1 malignant properties, according to a recent study.
A protein has been identified that can inhibit cellular inflammation, a major contributor to the growth of cervical cancer.
The geometric shape of the outside edge of a cancerous tumor plays a significant role in activating tumor-seeding cells that lead to metastasis.
This fact sheet explains tumor markers and their current use in cancer care.
A next-generation immunotherapy may offer hope for treating high-grade glioma, an aggressive form of brain cancer that is notoriously hard to treat.
Internal mammary lymph nodes (IMLNs) identified at implant-protocol breast magnetic resonance imaging (MRI) are more likely to be benign than malignant.
